Table 1.

Patient baseline characteristics

Age ± stdev, y	69±7.5
Range, y	50-82
PSA ± stdev, ng/mL	7.4±3.2
Range, ng/mL	2.7-19.5
Gleason score 6	8 (16%)
Gleason score 7	42 (84%)
Primary GS 4	19 (38%)
Cores involved ± stdev (#)	4.1±2.4
Range	1-11
Cores involved ± stdev (%)	32±18
Range	8-80
Clinical T stage:
cT1c, %	86
cT2a, %	12
cT2b, %	2
NCCN Risk Stage
Low	8 (16%)
Intermediate, favorable	16 (32%)
Intermediate, unfavorable	26 (52%)
AUA score ± stdev	9±7
Range	0-25
SHIM score ± stdev	13±8.5
Range	0-26
Prostate volume ± stdev (cc)	63±28
Range	30-109